Physicians' human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: A national study

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 10, 2014, Pages 2126-2135

  Malo, Teri L ^a   Giuliano, Anna R ^a,b   Kahn, Jessica A ^c   Zimet, Gregory D ^d   Lee, Ji Hyun ^a,b   Zhao, Xiuhua ^a   Vadaparampil, Susan T ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ADVISORY COMMITTEE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FINANCIAL MANAGEMENT; GENERAL PRACTITIONER; HUMAN; IMMUNIZATION; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL SOCIETY; MEN'S HEALTH; PEDIATRICIAN; PHYSICIAN; PRACTICE GUIDELINE; PREDICTOR VARIABLE; SCHOOL CHILD; UNITED STATES; VACCINATION; YOUNG ADULT; ATTITUDE TO HEALTH; CLINICAL PRACTICE; INFORMATION PROCESSING; PAPILLOMAVIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; CHILD; DATA COLLECTION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; YOUNG ADULT;

EID: 84907487122     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0344     Document Type: Article

References (42)

1. Li D, Li H,WanH, Chen J, Gong G,WangH, et al. Multiscale registration of medical images based on edge preserving scale space with application in image-guided radiation therapy. Phys Med Biol 2012;57: 5187-204.
2. Hartwig S, Syrjanen S, Dominiak-Felden G, Brotons M, Castellsague X. Estimation of the epidemiological burden of human papillomavirusrelated cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 2012;12:30.
3. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. New Engl J Med 2011;365:1576-85.
4. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. New Engl J Med 2011;364: 401-11.
5. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113:3036-46.
6. Seto K, Marra F, Raymakers A, Marra CA. The cost effectiveness of human papillomavirus vaccines: a systematic review. Drugs 2012;72: 715-43.
7. Ahmed F, Temte JL, Campos-Outcalt D, Schunemann HJ. Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC). Vaccine 2011;29:9171-6.
8. Akinsanya-BeysolowIAdvisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group, Centers for Disease Control and Prevention (CDC). Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years-United States, 2014. MMWR Morb Mortal Wkly Rep 2014;63:108-9.
9. Iowa Department of Public Health. Immunization program, vaccines for children program, human papillomavirus (HPV) vaccine. [cited 2014 Mar 28]. Available from: http://www.idph.state.ia.us/adper/common/ pdf/immunization/vfc-hpv-jan2010.pdf.
10. American Academy of Pediatrics. AAP private payer advocacy update [accessed 2014 Jun 10]. Available from: http://www.aapca3.org/law/ ppa/ppa1010.pdf.
11. Centers for Disease Control and Prevention. VFC eligibility criteria [accessed 2014 Jun 10]. Available from: http://www.cdc.gov/vaccines/ programs/vfc/providers/eligibility.html.
12. Centers for Disease Control and Prevention. VFC detailed questions and answers for parents [accessed 2014 Jun 10]. Available from: http:// www.cdc.gov/vaccines/programs/vfc/parents/qa-detailed.html#f1.
13. Centers for Disease Control and Prevention. ACIP recommends all 11-12 year-old males get vaccinated againstHPV [accessed 2014 Jun 10]. Available from: http://www.cdc.gov/media/releases/2011/t1025-hpv-12yroldvaccine.html.
14. Wells K, Zucker JR, Hannan C. The impact of ACIP HPV vaccine permissive recommendation on state, local and territorial immunization programs. 45th National Immunization Conference. Washington, D.C., 2011.
15. Centers for Disease Control and Prevention. Immunization Program Operations Manual (IPOM) [accessed 2014 Jun 10]. Available from: http://www.cdc.gov/vaccines/imz-managers/guides-pubs/ipom/ basics.html.
16. Centers for Disease Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;59: 630-2.
17. Daley M, Liddon N, Crane L, Beaty B, Barrow J, Babbel C, et al. A national survey of pediatrician knowledge and attitudes regarding human papilloma virus vaccination. Pediatrics 2006;118:2280-9.
18. Weiss TW, Zimet GD, Rosenthal SL, Brenneman SK, Klein JD. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health 2010; 47:3-11.
19. Kahn JA, Zimet GD, Bernstein DI, Riedesel JM, Lan D, Huang B, et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 2005;37:502-10.
20. Kahn JA, Rosenthal SL, Tissot AM, Bernstein DI, Wetzel C, Zimet GD. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr 2007;7:367-73.
21. Riedesel JM, Rosenthal SL, Zimet GD, Bernstein DI, Huang B, Lan D, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005;18:391-8.
22. Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ, et al. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 2009;18:2325-32.
23. Rogers EM. Diffusion of innovations. New York, NY: Free Press; 2003. p. 221.
24. Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011; 29:8634-41.
25. Vadaparampil ST, Malo TL, Kahn JA, Salmon DA, Lee JH, Quinn GP, et al. Physicians' human papillomavirus vaccine recommendations, 2009 and 2011. Am J Prev Med 2014;46:80-4.
26. Allison MA, Dunne EF, Markowitz LE, O'Leary ST, Crane LA, Hurley LP, et al. HPV vaccination of boys in primary care practices. Acad Pediatr 2013;13:466-74.
27. Jaen CR, Stange KC, Nutting PA.Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract 1994;38:166-71.
28. Dillman D. Mail and internet surveys: the tailored design method. New York, NY: Wiley, 2000.
29. Smart DR, American Medical Association. Physician characteristics and distribution in the US. Chicago: American Medical Association, 2009.
30. Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 2013;103:164-9.
31. Lau M, Lin H, Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. Vaccine 2012;30:3112-8
32. Kramer MR, Dunlop AL. Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007. Matern Child Health J 2012;16:S102-10.
33. Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG. National health care visit patterns of adolescents: implications for delivery ofnewadolescent vaccines. ArchPedAdolescMed2007;161:252-9.
34. Ishibashi KL, Koopmans J, Curlin FA, Alexander KA, Ross LF. Paediatricians' attitudes and practices towards HPV vaccination. Acta Paediatr 2008;97:1550-6.
35. Young JL, Bernheim RG, Korte JE, Stoler MH, Guterbock TM, Rice LW. Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol 2011;24:380-5.
36. Berwick DM. Disseminating innovations in health care. JAMA 2003; 289:1969-75.
37. Centers for Disease Control and Prevention. HPV-associated anal cancer rates by race and ethnicity [accessed 2012 Dec 21]. Available from: http://www.cdc.gov/cancer/hpv/statistics/anal.htm.
38. Centers for Disease Control and Prevention. Sexually transmitted disease sureveillance 2010 [accessed 2012 Dec 21]. Available from: http://www.cdc.gov/std/stats10/surv2010.pdf.
39. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 2014; 168:76-82.
40. Perkins RB, Clark JA. Providers' attitudes toward human papillomavirus vaccination in young men: challenges for implementation of 2011 recommendations. Am J Mens Health 2012;6:320-3.
41. Krieger JL, Katz ML, Kam JA, Roberto A. Appalachian and non-Appalachian pediatricians' encouragement of the human papillomavirus vaccine: implications for health disparities. Women's Health Issues 2012;22:e19-e26.
42. Roberto AJ, Krieger JL, Katz ML, Goei R, Jain P. Predicting pediatricians' communication with parents about the human papillomavirus (hpv) vaccine: an application of the theory of reasoned action. Health Commun 2011;26:303-12.